Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-04-20

FDA Approved: BENZONATATE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for BENZONATATE from Bionpharma Inc., confirming an additional approval for this generic cough suppressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benzonatate (BENZONATATE)

Snippet

SUPPL AP for BENZONATATE (BENZONATATE)